Outreach & Events

Events and Happenings at Munevar & Associates, Inc.In line with our mission to expand opportunities by which we can drive the advancements and breakthroughs currently taking place in the life science research and development space we created Science Shaping Our World – SHOWTM.

SHOWTM, is an ongoing seminar/networking series that highlights cutting edge life science research and translation. It’s mission is to bring science, technology, and multidisciplinary networking to a wide and diverse audience, spanning a broad depth and breadth of life science research, translation, and development topics.

Additionally, throughout the year we produce novel programing as well as take part in a  number of  science, technology, networking, and entrepreneurial events such as the Life Science Innovation & Technology Forum (IGNITE) piloted in 2011 in partnership with Biotech Vendor Services.

These events are a great opportunity to meet our team, reconnect with old colleagues, and meet new colleagues, as well as lend your voice, thoughts, and insight to the life science community working to bridge bench to bedside.

Science Shaping Our World (SHOW)  

Date City Venue
09/28/17 Boston, MA Auditorium A and B-Boston Children’s Hospital (BCH)
Time: 6:00pm. Admission: $15.00. Address: 1 Autumn Street. Science Shaping Our World-SHOW is an ongoing seminar and networking series that highlights cutting edge, translational, life science research and development. This season of SHOW is focused on the scientist-entrepreneur where we will be highlighting companies and innovations created by researchers and clinicians addressing a broad spectrum of healthcare need. Speakers for September’s SHOW event include: 1. David Raiser, PhD, Co-founder and CEO at Aldatu Biosciences – Aldatu Biosciences is developing innovative diagnostic tools based on its proprietary genotyping platform, PANDAA and focused on commercializing products that address diagnostic challenges in global health, primarily in HIV and other infectious diseases, and which improve both the quality of patient care and healthcare cost-efficiency. Prior to founding Aldatu, David worked in biotech and university technology transfer, and led a course on Healthcare Commercialization and Innovation at Harvard Medical School. 2. Barbara Fox, PhD, Founder and CEO at Tilos Therapeutics, Inc. – Tilos Therapeutics is harnessing the power of the immune system to develop new therapies for the treatment of cancer, fibrosis and related disorders. She has previously served as Entrepreneur-in-Residence at Partners Innovation Fund, founder and CEO of Avaxia Biologics, founder and CSO of Recovery Pharmaceuticals, VP Discovery and Immunology at ImmuLogic Pharmaceutical Corp., and Associate Professor of Rheumatology at the U. Maryland School of Medicine. 3. Serban Georgescu, MD CEO and Co-Founder at NotoVox – NotoVox provides quality and cost of care through a novel and disruptive technology translating physicians’ “familiar thinking” into medical codes that is fast and intuitive. He is a physician with over 19 years of cardiology, research and business experience. Dr. Georgescu continues to lead due diligence efforts at Massachusetts Medical Angels (MA2), a life sciences-focused angel investment group. 4. Elizabeth (Liz) Reczek, PhD CEO at SeqLL – Seqll seeks to harness the power of next generation sequencing (NGS) technology, and True Single Molecule Sequencing (tSMS), and bring them to the research and healthcare communities. By bringing together top-level scientists and engineers with extensive expertise in tSMS technology, SeqLL is uniquely positioned to address gaps left by standard sequencing technologies in RNA transcriptome analysis, specialty DNA analysis and beyond. Please join us for an amazing evening of the science entrepreneurship and networking. Event pre-registration is required with event sign-in beginning at 6:00 PM. Light food and refreshments will be provided. Buy Tickets More information

Subscribe: RSS | iCal